The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients.

The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients.

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Barnett, G, Flashman, E, Kelly, D, Schofield, C, Gershlick, A
التنسيق: Conference item
منشور في: 2013
الوصف
الملخص:

مواد مشابهة